EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Anakinra in a Preterm Infant with Bronchopulmonary Dysplasia: A Case Report

Simona Fattore iD, Chiara Tirone iD, Alessandro Perri iD, Francesca Paola Fusco, Simonetta Frezza, Milena Tana, Donato Rigante iD, Davide De Tomaso, Nicoletta Menzella iD, Alessandra Lio, Francesca Serrao iD, Stefano Nobile iD und 4 weitere

Children · 22.05.2026 · 13 (6) · 717

DOI: 10.3390/children13060717 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Children, online erschienen am 22.05.2026. Verfasst von Simona Fattore und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bronchopulmonary dysplasia (BPD) remains a major complication of extreme prematurity, driven in part by persistent inflammation. Interleukin (IL)-1–mediated signaling plays a central role in sustaining lung injury, making IL-1 blockade a potential therapeutic target. Evidence on the use of anakinra, a recombinant IL-1 receptor antagonist, in neonatal BPD is still limited. We report the case of a female preterm infant (28+2 weeks’ gestation, birth weight 800 g, −1.41 zs) affected by BPD requiring prolonged respiratory support. Due to persistent respiratory failure despite standard therapies, off-label treatment with subcutaneous anakinra (5 mg/kg twice daily) was initiated at 150 days of life. Clinical respiratory parameters and exploratory salivary inflammatory biomarkers (IL-6 and soluble urokinase plasminogen activator receptor, suPAR) were longitudinally monitored. Following anakinra initiation, the patient showed a gradual improvement in respiratory parameters, with reduction in oxygen requirement, mean airway pressure, and improved gas exchange. Respiratory support was gradually de-escalated from nasal intermittent positive pressure ventilation to continuous positive airway pressure and subsequently to high-flow nasal cannula. Salivary suPAR levels demonstrated a decreasing trend, while IL-6 showed transient fluctuations, partly associated with intercurrent infections. Treatment was generally well tolerated during the observation period. The infant was discharged on minimal respiratory support, with continued improvement during follow-up. This case suggests a possible role of IL-1 blockade in the modulation of persistent inflammation in BPD with a refractory clinical course, although the observed clinical course may also reflect the natural evolution of the disease. Longitudinal salivary biomarkers may represent a feasible, exploratory, non-invasive approach to describe inflammatory dynamics over time. Larger prospective studies are needed to evaluate the efficacy, safety, and optimal treatment protocols of anakinra.

Schlagwörter

Stichwörter der Autor:innen

anakinrabronchopulmonary dysplasiainnovative biotechnologiesinterleukin-1neonatespersonalized medicine

Autor:innen und Institutionen

  • Division of Neonatology, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Department of Women and Child Health Sciences, Child Health Area, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.
  • Division of Pediatrics, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • U.O.C. Farmacia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Unit of Chemistry, Biochemistry and Molecular Biology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
  • Department of Basic Biotechnological Sciences, Intensive Care and Perioperative Clinics, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.

ORCID-Profile: Simona Fattore, Chiara Tirone, Alessandro Perri, Donato Rigante, Nicoletta Menzella, Francesca Serrao, Stefano Nobile, Silvia Baroni, Simonetta Costa, Giovanni Vento

Zitieren

APA

Fattore, S., Tirone, C., Perri, A., Fusco, F. P., Frezza, S., Tana, M., Rigante, D., De Tomaso, D., Menzella, N., Lio, A., Serrao, F., Nobile, S., Piras, A., Baroni, S., Costa, S., & Vento, G. (2026). Anakinra in a Preterm Infant with Bronchopulmonary Dysplasia: A Case Report. Children, 13(6), 717. https://doi.org/10.3390/children13060717

Vancouver

Fattore S, Tirone C, Perri A, Fusco FP, Frezza S, Tana M, et al. Anakinra in a Preterm Infant with Bronchopulmonary Dysplasia: A Case Report. Children. 2026;13(6):717. doi:10.3390/children13060717

BibTeX
@article{Fattore2026,
  author = {Fattore, Simona and Tirone, Chiara and Perri, Alessandro and Fusco, Francesca Paola and Frezza, Simonetta and Tana, Milena and Rigante, Donato and De Tomaso, Davide and Menzella, Nicoletta and Lio, Alessandra and Serrao, Francesca and Nobile, Stefano and Piras, Andrea and Baroni, Silvia and Costa, Simonetta and Vento, Giovanni},
  title = {Anakinra in a Preterm Infant with Bronchopulmonary Dysplasia: A Case Report},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {6},
  pages = {717},
  doi = {10.3390/children13060717}
}
Kostenlos starten →